BIOCRYST PHARMACEUTICALS, INC. (BCRX) Return on equity 2016–2019
BIOCRYST PHARMACEUTICALS, INC. (BCRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-284.7%FY2019 · since FY2016: -3494.6% → -284.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | -284.7% | -79.0 pp |
| FY2018 | -205.7% | -127.1 pp |
| FY2017 | -78.5% | +3416.0 pp |
| FY2016 | -3494.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice